Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico

BACKGROUND: The first case of SARS-CoV-2 in Mexico was reported in February 2020, since then, high rates of mortality due to COVID-19 have been found. Cytokine storm is linked to the severity and decreasing the survival among infected patients by COVID-19. The serum levels of Interleukin 6 (IL-6) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Avila-Nava, Azalia, Cortes-Telles, Arturo, Torres-Erazo, Darwin, López-Romero, Stephanie, Chim Aké, Rodolfo, Gutiérrez Solis, Ana Ligia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052471/
https://www.ncbi.nlm.nih.gov/pubmed/33896708
http://dx.doi.org/10.1016/j.cyto.2021.155543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052471/
https://www.ncbi.nlm.nih.gov/pubmed/33896708
http://dx.doi.org/10.1016/j.cyto.2021.155543

Ejemplares similares